Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Nicotinamide Riboside Chloride (NIAGEN) in iPSC-RGC Research
2026-05-20
Explore how Nicotinamide Riboside Chloride (NIAGEN) advances iPSC-derived retinal ganglion cell (RGC) modeling, bridging metabolic modulation with cutting-edge neurodegenerative disease research. Discover workflow-critical insights for metabolic dysfunction studies.
-
Estradiol Benzoate: Workflow-Driven Advances in Estrogen Rec
2026-05-20
Estradiol Benzoate empowers researchers to achieve reproducible, high-sensitivity estrogen receptor signaling experiments. This article details step-by-step protocols, troubleshooting strategies, and real-world comparative advantages that set APExBIO’s offering apart in hormone receptor assay optimization.
-
Cisplatin (CDDP): Optimizing Apoptosis and Chemoresistance A
2026-05-19
Cisplatin (CDDP) empowers researchers to drive robust apoptosis assays, dissect tumor growth inhibition, and unravel chemoresistance in cancer models. This guide delivers evidence-based workflows, actionable troubleshooting, and new insights from metabolic reprogramming studies to maximize assay reproducibility with APExBIO's high-purity Cisplatin.
-
CAFs-Secreted Fatty Acids Drive Oral Cancer via Lipid Raft A
2026-05-19
This study reveals that fatty acids secreted by cancer-associated fibroblasts (CAFs) facilitate oral squamous cell carcinoma (OSCC) progression by promoting lipid raft formation and activating oncogenic signaling. The findings highlight a novel metabolic axis within the tumor microenvironment, with implications for future therapeutic strategies targeting lipid metabolism in OSCC.
-
ECL Chemiluminescent Substrate Detection Kit (Hypersensitive
2026-05-18
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) addresses the need for highly sensitive detection of low-abundance proteins in Western blot and related immunodetection assays. It is most effective for users requiring low picogram sensitivity and extended signal duration on nitrocellulose or PVDF membranes, but should not be used for diagnostic or medical purposes as per the manufacturer’s restrictions.
-
Cy3 NHS ester (non-sulfonated): Technical Use in Biomolecule
2026-05-18
Cy3 NHS ester (non-sulfonated) provides a robust solution for fluorescent labeling of proteins, peptides, and oligonucleotides where high signal intensity and compatibility with organic co-solvents are required. It should not be used for delicate proteins incompatible with DMSO or DMF or where aqueous-only labeling is essential.
-
GnRH Antagonists Modified with 3-(2-Methoxy-5-Pyridyl)-Alani
2026-05-17
This study presents the synthesis and biological evaluation of novel GnRH antagonist analogs with 3-(2-methoxy-5-pyridyl)-alanine at position 3. The research elucidates stereochemical effects on GnRH receptor antagonism and duration of action, informing future peptide design for reproductive and endocrine applications.
-
T7 RNA Polymerase: Optimized In Vitro RNA Synthesis Workflow
2026-05-16
APExBIO’s T7 RNA Polymerase streamlines high-yield, high-specificity RNA synthesis—essential for mRNA vaccine production and advanced RNAi research. Learn how to maximize performance, troubleshoot bottlenecks, and harness new therapeutic frontiers inspired by landmark RNA studies.
-
Molidustat (BAY85-3934): HIF-PH Inhibition for Renal Anemia
2026-05-15
Molidustat (BAY85-3934) is a potent hypoxia-inducible factor prolyl hydroxylase inhibitor that stabilizes HIF and stimulates endogenous erythropoietin production. This mechanism directly addresses anemia in chronic kidney disease by promoting physiologic erythropoietin expression without supraphysiological spikes. APExBIO supplies Molidustat as a research-grade solid compound with documented selectivity and application parameters.
-
Novobiocin Sodium in Bacterial DNA Replication: Mechanistic
2026-05-15
Explore the advanced mechanistic insights and research applications of Novobiocin Sodium, an aminocoumarin antibiotic essential for DNA gyrase inhibition and cell cycle studies. This article offers a practical, protocol-focused analysis distinct from conventional reviews.
-
CFTRinh-172: Mechanistic Insights and Protocols for Epitheli
2026-05-14
Explore the molecular specificity and advanced applications of CFTRinh-172, a leading CFTR inhibitor, for dissecting chloride channel signaling pathways in epithelial models. This article uniquely bridges mechanistic findings with actionable research protocols.
-
Peripheral Endosome Entrapment Limits LNP Trafficking and Es
2026-05-14
This study reveals that lipid nanoparticles (LNPs) trapped in peripheral endosomes—but not lysosomes—significantly impair intracellular trafficking and endosomal escape, a key barrier for nucleic acid delivery. Using advanced LNP labeling and endolysosomal activity modulation, the findings reshape our understanding of intracellular routes critical for effective RNA therapeutics and highlight new parameters for optimizing delivery systems.
-
4-Hydroxytamoxifen: Technical Use and Protocol Guidelines
2026-05-13
4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for research applications in breast cancer, prostate cancer, and cardiac myocyte calcium handling studies. It is suited for workflows requiring DMSO-soluble reagents, but should not be used where aqueous or ethanol solubility is essential. Researchers must adhere to strict storage and handling protocols for reproducible results.
-
Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Protein,
2026-05-13
Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides via reaction with primary amines, supporting sensitive detection in biomedical imaging workflows. Its use is optimal when organic co-solvents are acceptable, but it should be avoided for strictly aqueous protocols or long-term dye solution storage. Direct application guidance is grounded in product specifications and validated workflow practices.
-
Cy7 NHS Ester: Technical Guide for Near-Infrared Biomolecule
2026-05-12
Cy7 NHS Ester (SKU A8109) provides a hydrophilic, sulfonated near-infrared dye solution for protein and peptide labeling where high water solubility and minimal fluorescence quenching are critical. It is best suited for labeling sensitive biomolecules for non-destructive imaging. It is not recommended for workflows requiring long-term dye solution storage or non-aqueous labeling conditions.